Literature DB >> 22569087

Adverse effects of coexistence of sarcopenia and metabolic syndrome in Japanese women.

K Sanada1, M Iemitsu, H Murakami, Y Gando, H Kawano, R Kawakami, I Tabata, M Miyachi.   

Abstract

BACKGROUND/
OBJECTIVES: Little information is available regarding the interactions of sarcopenia and metabolic syndrome (MetS) in the risks of these age-associated diseases in women. The present cross-sectional study was performed to investigate whether the coexistence of sarcopenia and MetS further increases the risks of lifestyle-related diseases in Japanese women. SUBJECTS/
METHODS: Healthy Japanese women (n=533) aged 30-84 participated in this study. MetS was defined as higher body mass index, fasting plasma glucose, systolic or diastolic blood pressure and blood lipid abnormalities. Appendicular muscle mass and bone mineral density (BMD) were measured using dual-energy X-ray absorptiometry. The criterion of low muscle mass and strength defined median skeletal muscle index (appendicular muscle mass/height², kg/m²) and handgrip strength.
RESULTS: Two-way ANCOVA with adjustment for age, body fat percentage and whole-body lean tissue mass indicated that sarcopenia and MetS interacted to produce a significant effect on HbA1c, systolic blood pressure, triglycerides and brachial-ankle pulse wave velocity in Japanese women. The systolic blood pressure, triglycerides and brachial-ankle pulse wave velocity were significantly higher in women with coexisting sarcopenia and MetS than in healthy controls or in those with sarcopenia or MetS alone. The HbA1c in the coexisting sarcopenia and MetS group was higher than in healthy controls and sarcopenia subjects.
CONCLUSIONS: The coexistence of sarcopenia and MetS further increases the risks of cardiovascular diseases, such as type 2 diabetes mellitus, hypertension, arterial stiffness and hyperlipidemia even adjustment of age and body composition in adult Japanese women.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22569087     DOI: 10.1038/ejcn.2012.43

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  17 in total

1.  Effects of Progressive Walking and Stair-Climbing Training Program on Muscle Size and Strength of the Lower Body in Untrained Older Adults.

Authors:  Hayao Ozaki; Takashi Nakagata; Toshinori Yoshihara; Tomoharu Kitada; Toshiharu Natsume; Yoshihiko Ishihara; Pengyu Deng; Hiroyuki Kobayashi; Shuichi Machida; Hisashi Naito
Journal:  J Sports Sci Med       Date:  2019-11-19       Impact factor: 2.988

Review 2.  Nonalcoholic fatty liver disease and aging: epidemiology to management.

Authors:  Marco Bertolotti; Amedeo Lonardo; Chiara Mussi; Enrica Baldelli; Elisa Pellegrini; Stefano Ballestri; Dante Romagnoli; Paola Loria
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

3.  Muscle Size and Strength of the Lower Body in Supervised and in Combined Supervised and Unsupervised Low-Load Resistance Training.

Authors:  Hayao Ozaki; Shuji Sawada; Takuya Osawa; Toshiharu Natsume; Toshinori Yoshihara; Pengyu Deng; Shuichi Machida; Hisashi Naito
Journal:  J Sports Sci Med       Date:  2020-11-19       Impact factor: 2.988

4.  A positive association between stroke risk and sarcopenia in men aged ≥ 50 years, but not women: results from the Korean National Health and Nutrition Examination Survey 2008-2010.

Authors:  S Park; J-O Ham; B-K Lee
Journal:  J Nutr Health Aging       Date:  2014-11       Impact factor: 4.075

5.  Associations of Low Muscle Mass and the Metabolic Syndrome in Caucasian and Asian Middle-aged and Older Adults.

Authors:  D Scott; M S Park; T N Kim; J Y Ryu; H C Hong; H J Yoo; S H Baik; G Jones; K M Choi
Journal:  J Nutr Health Aging       Date:  2016-03       Impact factor: 4.075

6.  A different role of angiotensin II type 1a receptor in the development and hypertrophy of plantaris muscle in mice.

Authors:  Hirofumi Zempo; Jun-Ichi Suzuki; Masahito Ogawa; Ryo Watanabe; Mitsuaki Isobe
Journal:  J Appl Genet       Date:  2015-05-30       Impact factor: 3.240

7.  Sarcopenia is associated with cardiovascular risk in men with COPD, independent of adiposity.

Authors:  Ah Young Leem; Young Sam Kim; Kung Soo Chung; Moo Suk Park; Young Ae Kang; Young-Mok Park; Ji Ye Jung
Journal:  Respir Res       Date:  2022-07-13

Review 8.  Sarcopenia and sarcopenic obesity.

Authors:  Kyung Mook Choi
Journal:  Korean J Intern Med       Date:  2016-11-01       Impact factor: 2.884

9.  Sarcopenia and non-alcoholic fatty liver disease: Is there a relationship? A systematic review.

Authors:  Cristiane V Tovo; Sabrina A Fernandes; Caroline Buss; Angelo A de Mattos
Journal:  World J Hepatol       Date:  2017-02-28

Review 10.  Association between Sarcopenia and Metabolic Syndrome in Middle-Aged and Older Non-Obese Adults: A Systematic Review and Meta-Analysis.

Authors:  Huaqi Zhang; Song Lin; Tianlin Gao; Feng Zhong; Jing Cai; Yongye Sun; Aiguo Ma
Journal:  Nutrients       Date:  2018-03-16       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.